These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15309019)

  • 1. Distinction of endometrial stromal sarcomas from 'hemangiopericytomatous' tumors using a panel of immunohistochemical stains.
    Bhargava R; Shia J; Hummer AJ; Thaler HT; Tornos C; Soslow RA
    Mod Pathol; 2005 Jan; 18(1):40-7. PubMed ID: 15309019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic endometrial stromal sarcoma of the lung: importance of immunohistochemical staining, clinical history and imaging studies.
    Mentrikoski MJ; Zhao C; Zhang J; Wang HL; McMahon LA; Yang Q; Li F; Xu H
    Biotech Histochem; 2012 Jan; 87(1):35-9. PubMed ID: 21838613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelioid endometrial and endometrioid stromal tumors: a report of four cases emphasizing their distinction from epithelioid smooth muscle tumors and other oxyphilic uterine and extrauterine tumors.
    Oliva E; Clement PB; Young RH
    Int J Gynecol Pathol; 2002 Jan; 21(1):48-55. PubMed ID: 11781523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical Expression of Different Subtypes of Cytokeratins by Endometrial Stromal Sarcoma.
    Rahimi S; Akaev I; Marani C; Chopra M; Yeoh CC
    Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):466-470. PubMed ID: 29406332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies.
    Oliva E; Young RH; Amin MB; Clement PB
    Am J Surg Pathol; 2002 Apr; 26(4):403-12. PubMed ID: 11914617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial sarcomas: an immunohistochemical and JAZF1 re-arrangement study in low-grade and undifferentiated tumors.
    Jakate K; Azimi F; Ali RH; Lee CH; Clarke BA; Rasty G; Shaw PA; Melnyk N; Huntsman DG; Laframboise S; Rouzbahman M
    Mod Pathol; 2013 Jan; 26(1):95-105. PubMed ID: 22918161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of STAT6, CD34, CD99 and BCL-2 for diagnosing solitary fibrous tumors/hemangiopericytomas.
    Han Y; Zhang Q; Yu X; Han X; Wang H; Xu Y; Qiu X; Jin F
    Int J Clin Exp Pathol; 2015; 8(10):13166-75. PubMed ID: 26722515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed tumors of the vagina: an immunohistochemical study of 13 cases with emphasis on the cell of origin and potential aid in differential diagnosis.
    Oliva E; Gonzalez L; Dionigi A; Young RH
    Mod Pathol; 2004 Oct; 17(10):1243-50. PubMed ID: 15154010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma.
    Zhu XQ; Shi YF; Cheng XD; Zhao CL; Wu YZ
    Gynecol Oncol; 2004 Jan; 92(1):71-9. PubMed ID: 14751141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical profiling of cytokeratin expression by endometrial stroma sarcoma.
    Adegboyega PA; Qiu S
    Hum Pathol; 2008 Oct; 39(10):1459-64. PubMed ID: 18619644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms.
    McCluggage WG; Sumathi VP; Maxwell P
    Histopathology; 2001 Sep; 39(3):273-8. PubMed ID: 11532038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic use of nuclear beta-catenin expression for the assessment of endometrial stromal tumors.
    Jung CK; Jung JH; Lee A; Lee YS; Choi YJ; Yoon SK; Lee KY
    Mod Pathol; 2008 Jun; 21(6):756-63. PubMed ID: 18376386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation.
    Yilmaz A; Rush DS; Soslow RA
    Am J Surg Pathol; 2002 Sep; 26(9):1142-50. PubMed ID: 12218570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial stromal tumors: an update on a group of tumors with a protean phenotype.
    Oliva E; Clement PB; Young RH
    Adv Anat Pathol; 2000 Sep; 7(5):257-81. PubMed ID: 10976906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlations.
    Croce S; Hostein I; Ribeiro A; Garbay D; Velasco V; Stoeckle E; Guyon F; Floquet A; Neuville A; Coindre JM; MacGrogan G; Chibon F
    Mod Pathol; 2013 Oct; 26(10):1390-400. PubMed ID: 23599159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent expression of bcl-2 protein in solitary fibrous tumors.
    Hasegawa T; Matsuno Y; Shimoda T; Hirohashi S; Hirose T; Sano T
    Jpn J Clin Oncol; 1998 Feb; 28(2):86-91. PubMed ID: 9544821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of Combined BCOR, Cyclin D1, and CD10 in Differentiating Endometrial Stromal Sarcoma From Other Uterine Spindle Cell Lesions.
    Abouelkhair MB; Shakweer MM; Faisal MM; Nasreldin MH; Farid LM
    Appl Immunohistochem Mol Morphol; 2024 Aug; 32(7):326-335. PubMed ID: 38961542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coincident expression of beta-catenin and cyclin D1 in endometrial stromal tumors and related high-grade sarcomas.
    Kurihara S; Oda Y; Ohishi Y; Kaneki E; Kobayashi H; Wake N; Tsuneyoshi M
    Mod Pathol; 2010 Feb; 23(2):225-34. PubMed ID: 19898427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology.
    Chiang S; Lee CH; Stewart CJR; Oliva E; Hoang LN; Ali RH; Hensley ML; Arias-Stella JA; Frosina D; Jungbluth AA; Benayed R; Ladanyi M; Hameed M; Wang L; Kao YC; Antonescu CR; Soslow RA
    Mod Pathol; 2017 Sep; 30(9):1251-1261. PubMed ID: 28621321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemangiopericytoma: histopathological pattern or clinicopathologic entity?
    Nappi O; Ritter JH; Pettinato G; Wick MR
    Semin Diagn Pathol; 1995 Aug; 12(3):221-32. PubMed ID: 8545589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.